Targeting JAK–STAT signaling for autoimmune diseases: current understanding, clinical advances, and emerging directions

Immunology and Cell Biology · Published 2026-01-09 · DOI 10.1111/imcb.70078

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1111/imcb.70078

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Combination Therapy with Upadacitinib and Acitretin in Recalcitrant Darier Disease: A Case Report · Acta Dermato-Venereologica · 2026 · Cites or is cited by this article
• Vascular gatekeepers of central nervous system immunity · Immunology and Cell Biology · 2026 · Same journal
• One cell, many fates: transcriptional networks governing CD8 + T cell differentiation · Immunology and Cell Biology · 2026 · Same journal
• ICB Special Feature: Highlights of 2025 · Immunology and Cell Biology · 2026 · Same journal
• Highlights of 2025: plasma cell biology · Immunology and Cell Biology · 2026 · Same journal
• CD49a expression defines a metabolically robust, cytokine‐biased liver NK cell subset in rhesus macaques during lentivirus infection · Immunology and Cell Biology · 2026 · Same journal
• Molecular insights into the anti‐inflammatory and antifibrotic effects of licorice–ginger decoction in experimental models of inflammatory arthritis‐associated lung fibrosis · Immunology and Cell Biology · 2026 · Same journal
• Highlights of 2025: the B‐side of LEF1 · Immunology and Cell Biology · 2026 · Same journal
• Age‐related differences in mRNA vaccine immunogenicity and adjuvancy · Immunology and Cell Biology · 2026 · Same journal
• Exploring SIK2 ‐ CXCL5 interactions in neutrophils: A novel mechanism for modulating IL ‐23 and psoriasis progression · Immunology and Cell Biology · 2026 · Same journal